D Souza S, Obeid W, Hernandez J, Hu D, Wen Y, Moledina D
Sci Rep. 2024; 14(1):8516.
PMID: 38609491
PMC: 11014899.
DOI: 10.1038/s41598-024-59104-5.
Rogulska K, Wojciechowska-Koszko I, Dolegowska B, Kwiatkowska E, Roszkowska P, Kapczuk P
J Immunol Res. 2022; 2022:6572338.
PMID: 35669103
PMC: 9167141.
DOI: 10.1155/2022/6572338.
Tamma G, Di Mise A, Ranieri M, Centrone M, Venneri M, DAgostino M
Front Physiol. 2022; 13:858867.
PMID: 35514354
PMC: 9065601.
DOI: 10.3389/fphys.2022.858867.
Hong S, Xia Q, Xu J, Liu C, Sun J, Xun Y
BMC Med Genomics. 2022; 15(1):7.
PMID: 35016690
PMC: 8751247.
DOI: 10.1186/s12920-022-01157-4.
Ibis F, Yu T, Penha F, Ganguly D, Nuhu M, Van der Heijden A
Biomicrofluidics. 2021; 15(6):064103.
PMID: 34853626
PMC: 8610605.
DOI: 10.1063/5.0063714.
The role of osteopontin in kidney diseases.
Kaleta B
Inflamm Res. 2018; 68(2):93-102.
PMID: 30456594
DOI: 10.1007/s00011-018-1200-5.
Osteopontin in bone mineral density of very old Brazilians.
Souza V, Freitas W, Quaglia L, Santos S, Cordova C, Sposito A
J Bone Miner Metab. 2013; 31(4):449-54.
PMID: 23515922
DOI: 10.1007/s00774-013-0425-1.
Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice.
Hirose M, Tozawa K, Okada A, Hamamoto S, Higashibata Y, Gao B
Urol Res. 2011; 40(2):121-9.
PMID: 21833789
DOI: 10.1007/s00240-011-0400-z.
Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment.
Chiang T, Chang I, Lee H, Lee H, Huang C, Cheng Y
Osteoporos Int. 2010; 22(2):577-85.
PMID: 20734029
DOI: 10.1007/s00198-010-1327-x.
Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.
Thurgood L, Cook A, Sorensen E, Ryall R
Urol Res. 2010; 38(5):357-76.
PMID: 20652561
DOI: 10.1007/s00240-010-0300-7.
Increased serum osteopontin is a risk factor for osteoporosis in menopausal women.
Chang I, Chiang T, Yeh K, Lee H, Cheng Y
Osteoporos Int. 2010; 21(8):1401-9.
PMID: 20238102
DOI: 10.1007/s00198-009-1107-7.
Subnanometer atomic force microscopy of peptide-mineral interactions links clustering and competition to acceleration and catastrophe.
Friddle R, Weaver M, Qiu S, Wierzbicki A, Casey W, De Yoreo J
Proc Natl Acad Sci U S A. 2009; 107(1):11-5.
PMID: 20018743
PMC: 2793304.
DOI: 10.1073/pnas.0908205107.
Surface aggregation of urinary proteins and aspartic Acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy.
Weaver M, Qiu S, Hoyer J, Casey W, Nancollas G, De Yoreo J
Calcif Tissue Int. 2009; 84(6):462-73.
PMID: 19294448
PMC: 2688023.
DOI: 10.1007/s00223-009-9223-0.
High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay.
Thurgood L, Grover P, Ryall R
Urol Res. 2008; 36(2):103-10.
PMID: 18478219
DOI: 10.1007/s00240-008-0139-3.
Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.
Qiu S, Wierzbicki A, Orme C, Cody A, Hoyer J, Nancollas G
Proc Natl Acad Sci U S A. 2004; 101(7):1811-5.
PMID: 14766970
PMC: 357009.
DOI: 10.1073/pnas.0307900100.
Phosphate is a specific signal for induction of osteopontin gene expression.
Beck Jr G, Zerler B, Moran E
Proc Natl Acad Sci U S A. 2000; 97(15):8352-7.
PMID: 10890885
PMC: 26951.
DOI: 10.1073/pnas.140021997.
